ALZN vs AMCR · $2.4M cap vs P/E 18, rev $23.51B
Alzamend Neuro Inc (ALZN) versus Amcor PLC (AMCR) — a side-by-side from cached financials, not a winner call.
Alzamend Neuro Inc (ALZN) is a biotechnology company listed on US.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
ALZN does not have a complete income-statement cache yet.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
ALZN currently screens at market cap $2.4M. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Not investment advice. Open the ALZN and AMCR stock pages for the full models.
Not investment advice.